Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine

Journal of Clinical Investigation

Volumn 98, Issue 10, 1996, Pages 2414-2424

  Mooser, Vincent ^a   Marcovina, Santica M ^b   White, Ann L ^c   Hobbs, Helen H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

heparin; kidney; lipoprotein(a); monkey; mouse

Indexed keywords

APOLIPOPROTEIN A1; LIPOPROTEIN A;

ADULT; ARTICLE; BABOON; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOREACTIVITY; KRINGLE DOMAIN; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SPECIES DIFFERENTIATION; URINARY EXCRETION;

EID: 0029832040     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119055     Document Type: Article

References (41)

1. Utermann, G. 1995. Lipoprotein(a). In The Metabolic Basis of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw Hill Inc., New York. 1887-1912.
2. Scanu, A.M. 1991. Lipoprotein(a) and atherosclerosis. Ann. Intern. Med. 115:209-218.
3. Liu, A.C., and R.M. Lawn. 1994. Vascular interactions of lipoprotein(a). Curr. Opin. Lipidol. 5:269-273.
4. Ikeo, K., K. Takahashi, and T. Gojohori. 1995. Different evolutionary histories of kringle and protease domains in serine proteases: a typical example of domain evolution. J. Mol. Evol. 40:331-336.
5. Yoshimura, T., N. Yuhki, M. Wang, A. Skee, and E.J. Leonard. 1993. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem. 268:15461-15468.
6. Morrisett, J., J. Gaubatz, R. Knapp, and J.G. Guevara. 1990. Structural properties of apo(a): a major apoprotein of human lipoprotein(a). In Lipoprotein(a). A. Scanu, editor. Academic Press, Inc., San Diego, CA. 53-74.
7. Lackner, C., J.C. Cohen, and H.H. Hobbs. 1993. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum. Mol. Genet. 2:933-940.
8. McLean, J.W., J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu, and R.M. Lawn. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature (Lond.). 330:132-137.
9. Van der Hoek, Y., W. Sangrar, G.P. Côté, J.J.P. Kastelein, and M.L. Koschinsky. 1994. Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. Arterioscler. Thromb. 14:1792-1798.
10. Mizuno, K., H. Inoue, M. Hagiya, S. Shimizu, T. Nose, Y. Shimohigashi, and T. Nakamura. 1994. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 269:1131-1136.
11. O'Reilly, M.S., L. Holmgren, Y. Shing, C. Chen, A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:315-328.
12. Oida, K., H. Takai, H. Maeda, S. Takahashi, A. Shimada, J. Suzuki, T. Tamai, T. Nakai, and S. Miyabo. 1992. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin. Chem. 38: 2244-2248.
13. Mooser, V., M.C. Seabra, M. Abedin, K.T. Landschulz, S. Marcovina, and H.H. Hobbs. 1996. Apo(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J. Clin. Invest. 97:858-864.
14. Marcovina, S.M., J.J. Albers, B. Gabel, M.L. Koschinsky, and V.P. Gaur. 1995. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin. Chem. 41:246-255.
15. Chiesa, G., H.H. Hobbs, M.L. Koschinsky, R.M. Lawn, S.D. Maika, and R.E. Hammer. 1992. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J. Biol. Chem. 267:24369-24374.
16. Linlon, M.F., R.V. Farese, G. Chiesa, D.S. Grass, P. Chin, R.E. Hammer, H.H. Hobbs, and S.G. Young. 1993. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 93:3029-3037.
17. Rainwater, D.L., G.S. Manis, and J.L. VandeBerg. 1989. Hereditary and dietary effects on apolipoprotein(a) isoforms and Lp(a) in baboons. J. Lipid Res. 30:549-558.
18. Lanford, R.E., K.D. Carey, L.E. Estlack, G.C. Smith, and R.V. Hay. 1989. Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell. Dev. Biol. 25:174-182.
19. Gaw, A., E. Boerwinkle, J.C. Cohen, and H.H. Hobbs. 1994. Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J. Clin. Invest. 93:2526-2534.
20. Koschinsky, M.L., J.E. Tomlinson, T.F. Zioncheck, K. Schwartz, D.L. Eaton, and R.M. Lawn. 1991. Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 30: 5044-5051.
21. Young, S.G., S.J. Bertics, L.K. Curtiss, and J.L. Witztum. 1987. Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J. Clin. Invest. 79:1831-1841.
22. Menzel, H.J., H. Dieplinger, C. Lackner, F. Hoppichler, J.K. Lloyd, D.R. Muller, C. Labeur, P.J. Talmud, and G. Utermann. 1990. Abetalipoproteinemia with an apoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J. Biol. Chem. 265:981-986.
23. Azrolan, N., D. Gavish, and J.L. Breslow. 1991. Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (Apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J. Biol. Chem. 266:13866-13872.
24. Kraft, H.G., H.J. Menzel, F. Hoppichler, W. Vogel, and G. Utermann. 1989. Changes in genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J. Clin. Invest. 83:137-142.
25. Callow, M.J., J. Verstuyft, R. Tangirala, W. Palinski, and E.M. Rubin. 1995. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein(a). J. Clin. Invest. 96:1639-1646.
26. Farabaugh, P.J. 1993. Alternative readings of the genetic code. Cell. 74: 591-596.
27. Koschinsky, M.L., U. Beisiegel, D. Henne-Bruns, D.L. Eaton, and R.M. Lawn. 1990. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry. 29:640-644.
28. Hixon, J.E., M.L. Britten, G.S. Manis, and D.L. Rainwater. 1989. Apolipoprotein(a) (apo(a)) glycoprotein isoforms result from size differences in apo(a) mRNA in baboons. J. Clin. Invest. 264:6013-6016.
29. White, A.L., D.L. Rainwater, and R.E. Lanford. 1993. Intracellular maturation of apolipoprotein(a) and assembly of lipoprotein(a) in primary baboon hepatocytes. J. Lipid Res. 34:509-517.
30. Wang, M., A. Skeel, and E.J. Leonard. 1996. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J. Clin. Invest. 97:720-727.
31. Koschinsky, M.L., G.P. Côté, B. Gabel, and Y.Y. Van der Hoek. 1993. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J. Biol. Chem. 268:19819-19825.
32. Brunner, C., H.G. Kraft, G. Utermann, and H.J. Muller. 1993. Cys4057 of apolipoprolein(a) is essential for lipoprotein(a) assembly. Proc. Natl. Acad. Sci. USA. 90:11643-11647.
33. Ernst, A., M. Helmhold, C. Brunner, A. Pethö-Schramm, V.W. Armstrong, and H. Müller. 1995. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringle 32-36 of human apolipoprotein(a). J. Biol. Chem. 270:6227-6234.
34. Scanu, A.M., L.A. Miles, G.M. Fless, D. Pfaffinger, J. Eisenbart, E. Jackson, J.L. Hoover-Plow, T. Brunck, and E.F. Plow. 1993. Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). J. Clin. Invest. 91:283-291.
35. Hoff, H.F., J. O'Neil, and A. Yashiro. 1993. Partial characterization of lipoproteins containing apo(a) in human atherosclerotic lesions. J. Lipid Res. 34:789-798.
36. Guyton, J.R., G.H. Dahlen, W. Patsch, J.A. Kautz, and A. Gotto, Jr. 1985. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. J. Clin. Invest. 5:265-272.
37. Sandholzer, C., E. Boerwinkle, N. Saha, M.C. Tong, and G. Utermann. 1992. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population. Evidence for the role of the apo(a) gene in coronary heart disease. J Clin. Invest. 89:1040-1046.
38. Parra, H.J., H. Mezdour, C. Cachera, M. Dracon, A. Tacquet, and J.C. Fruchart. 1987. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin. Chem. 33:721.
39. Haffner, S.M., K.K. Gruber, G. Aldrete, Jr., P.A. Morales. M.P. Stern, and K.R. Tuttle. 1992. Increased lipoprotein(a) concentrations in chronic renal failure. J. Am. Soc. Nephrol. 3:1156-1162.
40. Dieplinger, H., C. Lackner, F. Kronenberg, C. Sandholzer, K. Lhotta, F. Hoppichler, H. Graf, and P. Konig. 1993. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J. Clin. Invest. 91:397-401.
41. Hirata, K., S. Kikuchi, K. Saku, S. Jimi, B. Zhang, S. Naito, H. Hamaguchi, and K. Arakawa. 1993. Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. Kidney Int. 44: 1062-1070.